CB
48
-3
AFL
66
2
AIV
64
3
GPC
43
-2
CTAS
64
3
DIS
43
-2
DG
34
4
BLK
63
3
MAC
75
-4
ALL
47
-3
PCG
83
2
CCL
47
6
IP
62
-2
PYPL
31
-2
SYF
85
-5
BDX
61
2
JCI
44
3
NI
62
4
AN
61
-2
NOC
40
-3
CB
48
-3
AFL
66
2
AIV
64
3
GPC
43
-2
CTAS
64
3
DIS
43
-2
DG
34
4
BLK
63
3
MAC
75
-4
ALL
47
-3
PCG
83
2
CCL
47
6
IP
62
-2
PYPL
31
-2
SYF
85
-5
BDX
61
2
JCI
44
3
NI
62
4
AN
61
-2
NOC
40
-3
Financhill
Back

Enliven Therapeutics Stock Predictions

Buy
66

ELVN
Enliven Therapeutics

Last Price:
23.93
Seasonality Move:
-10.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Enliven Therapeutics Stock Forecast

  • Over the next 52 weeks, Enliven Therapeutics has on average historically risen by 36.8% based on the past 4 years of stock performance.
  • Enliven Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Enliven Therapeutics Stock Undervalued?
    The current Enliven Therapeutics [ELVN] share price is $24.00. The Score for ELVN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • ELVN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Enliven Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Enliven Therapeutics has on average historically risen by 36.8% based on the past 4 years of stock performance.

Enliven Therapeutics Stock Rating

Buy
66
Enliven Therapeutics (ELVN) is a Buy

Is Enliven Therapeutics overpriced?

  • Enliven Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Enliven Therapeutics Stock Price History

Is ELVN stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ELVN is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
enliventherapeutics.com

52-Week Data

52-Week High:
26.00
52-Week Low:
9.80

Prediction Charts

Market Cap:
1.13B
Price in USD:
24.00
Volume:
395.85K
Beta:
0.93

Technical Analysis

SMA50:
18.56
SMA100:
16.84
SMA200:
15.31
52-Wk Change:
21.03%

Stock Predictions

  • Is Enliven Therapeutics stock public?
    Yes, Enliven Therapeutics is a publicly traded company.
  • What is the Enliven Therapeutics stock quote today?
    The Enliven Therapeutics stock price is 24.00 USD today.
  • How to buy Enliven Therapeutics stock online?
    You can buy Enliven Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-26 16.72 17.18 17.52 16.16
Apr-29 17.41 17.79 18.79 16.56
Apr-30 17.93 17.39 18.36 17.35
May-1 17.68 18.08 18.76 17.68
May-2 18.29 20.99 21.13 18.29
May-3 21.81 22.65 23.00 21.35
May-6 22.88 22.91 22.96 22.20
May-7 22.92 24.70 25.00 22.92
May-8 24.34 24.49 24.60 23.72
May-9 24.85 23.85 25.16 23.62
May-10 23.86 23.43 23.90 22.99
May-13 24.29 24.49 24.70 24.14
May-14 24.83 23.87 25.00 23.83
May-15 24.84 24.00 24.85 23.56

Enliven Therapeutics Earnings

Enliven Therapeutics Earnings Report: Per Share Enliven Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Enliven Therapeutics Forecast Revenue Growth

Enliven Therapeutics Stock Analysis: Historical quarterly revenues per share for Enliven Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.00 per share.

* Enliven Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.